Skip to main content

Table 3 Adverse reactions

From: A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study

Grades of Adverse Reactions G1 G2 G3 G4 Total (Incidence %)
 Neutropenia 0 1 0 0 1.8
 Anemia 0 0 0 0 0
 Elevation of AST or ALT 0 1 4 0 9.1
 Elevation of creatinine 1 0 0 0 1.8
 Hyper bilirubinemia 0 0 1 0 1.8
 Anorexia 0 5 1 0 10.9
 Nausea 2 2 1 0 9.1
 Diarrhea 2 2 0 0 7.3
 Malaise 0 1 1 0 3.6
 Skin disorder 0 2 0 0 3.6
 Pneumonia 0 1 0 0 1.8
 Weight loss 0 0 1 0 1.8
 Others 1 1 0 0 3.6